Nasdaq-listed Aptorum Group and A*ccelerate seeks to develop up to 20 deeptech ventures up over the next five years.
Nasdaq-listed Aptorum Group, Aeneas Capital, and A*ccelerate Technologies, the enterprise office of A*STAR, have signed a US$90m agreement to co-create local deep tech startups in the healthcare and life sciences sector.
Through this agreement, Aptorum Group and A*ccelerate are looking at creating up to 20 deep tech ventures in Singapore over the next five years. These enterprises will use the technologies co-developed by A*STAR research institutes and Aptorum Group.
One of the areas both parties are looking into is the translation of A*STAR’s capabilities in medical image analytics and augmented reality, into real-time 2D and 3D magnetic resonance imaging (MRI) surgical imaging solutions for applications in the field of surgical robotics.
Aptorum Group and Aeneas Capital will also be launching a healthcare and life science strategic investment fund of up to US$200m. Aptorum Group and Aeneas Capital will also make acquisitions in identified technologies and businesses globally.
Do you know more about this story? Contact us anonymously through this link.